Surat, India – January 28, 2025: Ami Organics Limited (NSE: AMIORG, BSE: 543349) has announced its unaudited financial results for Q3 FY2024-25, reporting ₹249.87 crore in Revenue and ₹15.04 crore in net profit, reflecting a 51% YoY growth in Revenue. The company also disclosed its investment utilization from its preferential issue and QIP, reaffirming its commitment to expanding its electrolyte additives and specialty chemicals business.
Key Financial Highlights – Q3 FY2024-25 (Consolidated)
- Revenue from Operations: ₹249.87 crore (YoY increase of 51% from ₹166.44 crore)
- Total Income: ₹276.66 crore
- Profit Before Tax (PBT): ₹53.33 crore
- Net Profit (PAT): ₹15.04 crore (YoY increase from ₹17.81 crore)
- Earnings Per Share (EPS): ₹1.35 per share.
Nine-Month Performance (April – December 2024) (Consolidated)
- Total Revenue: ₹698.39 crore (YoY increase from ₹492.51 crore)
- Profit Before Tax (PBT): ₹133.32 crore
- Net Profit (PAT): ₹97.70 crore
- EPS: ₹24.39 per share.
Strategic Developments & Key Announcements
- Expansion in Electrolyte Additives & Specialty Chemicals:
- Investment of ₹2,687.27 lakh in electrolyte additives & allied businesses as part of ₹7,700 crore planned capex.
- The company plans to leverage its expertise in pharmaceuticals and specialty chemicals to expand into the battery materials and green energy sectors.
- Utilization of Preferential Issue Proceeds (₹9,909.99 lakh raised in May 2024):
- ₹2,976.71 lakh utilized by December 31, 2024.
- ₹6,933.28 lakh remains unutilized and is kept in fixed deposits.
- Utilization of QIP Proceeds (₹39,999.99 lakh raised in June 2024):
- ₹25,000 lakh was used for debt repayment.
- ₹1,753 lakh was used for capital expenditure (solar power projects, facility expansion).
- ₹9,583.91 lakh remains in fixed deposits.
- No Segment Diversification:
- The company remains focused on its core business of custom synthesis and specialty chemicals for pharmaceuticals and industrial applications.
Management Commentary
Naresh Kumar R. Patel, Chairman & Managing Director Ami Organics, stated:"Our strong revenue growth underscores the increasing demand for specialty chemicals in pharmaceuticals and emerging battery technologies. The strategic investments from our preferential issue and QIP proceeds position us for future expansion into high-growth markets.".
Market Outlook & Investor Takeaways
- Rapid growth in specialty chemicals demand, particularly in pharmaceuticals and battery technologies, supports long-term revenue expansion.
- Debt repayment from QIP strengthens the company's financial position and improves operational efficiency.
- Upcoming capital expenditure on solar power projects aligns with sustainability goals and energy cost optimization.